Physician profile
Majed Jeroudi
NPI 1154348050
$1,846.54
in general payments reported to CMS, 2019-2025
19 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $299 · 2021: $160 · 2022: $71.64 · 2023: $675 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $521.76 | 2019-2023 | |
| Pfizer INC. | $298.93 | 2023-2025 | |
| Fennec Pharmaceuticals, INC. | $214.97 | 2023 | Pedmark |
| Csl Behring | $183.03 | 2019-2023 | Hemgenix |
| Emmaus Medical, INC. | $153.35 | 2019-2025 | Endari |
| Global Blood Therapeutics, INC. | $123.03 | 2020-2022 | |
| Agios Pharmaceuticals, INC. | $53.62 | 2023 | Pyrukynd |
| Servier Pharmaceuticals LLC | $47.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.86 | 2019 | |
| Novo Nordisk INC | $34.03 | 2019-2023 | |
| Chiesi USA, INC. | $30.79 | 2023 | Ferriprox |
| Sobi, INC | $22.58 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $22.17 | 2023 | Imbruvica |
| Duchesnay USA Incorporated | $18.08 | 2022 | |
| Amgen INC. | $16.51 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $16.23 | 2019 | |
| Grifols USA, LLC | $16.00 | 2019 | |
| Medexus Pharma, INC. | $14.35 | 2021 | |
| Azurity Pharmaceuticals, INC. | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Majed Jeroudi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.